Status:
COMPLETED
The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms
Lead Sponsor:
Midwestern University
Conditions:
Healthy
Premenstrual Dysphoric Disorder
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to assess Mixhers HERTIME supplements efficacy in alleviating menstrual cycle symptoms.
Detailed Description
All participants, after providing written informed consent, will drink a daily self-administered powder-mix supplement in water of either placebo or Mixhers HERTIME for 120 consecutive days. Surveys w...
Eligibility Criteria
Inclusion
- Must be biologically female, must have a regular menstrual cycle (defined as a menstrual bleed every 23-35 days), must be a student, staff, or faculty member at Midwestern University Glendale, Arizona campus
Exclusion
- not pregnant or planning to become pregnant, must not be on anticoagulants, must not have allergies to lemon or stevia
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06136104
Start Date
August 30 2023
End Date
December 20 2023
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Midwestern University
Glendale, Arizona, United States, 85308